Autres langues KORU Medical Systems, Inc.

Actions

KRMD

US7599101026

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 01/05/2024			Varia. 5j.	Varia. 1 janv.
2,25 ^USD	+3,69%		+2,27%	-8,35%

01/05	Transcript : KORU Medical Systems, Inc., Q1 2024 Earnings Call, May 01, 2024
01/05	KORU Medical Systems, Inc. réaffirme ses prévisions financières pour l'ensemble de l'année 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M	01/05
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth	01/05
KORU Medical Systems, Inc. Reaffirmes Financial Guidance for the Full Year of 2024	01/05
KORU Medical Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024	17/04
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review	11/04
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference	18/03
KORU Medical Systems, Inc. Enters into Loan and Security Agreement with HSBC Ventures USA Inc	13/03
KORU Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
KORU Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q4 Revenue $7.2M, vs. Street Est of $6.9M	13/03
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance	13/03
KORU Medical Systems, Inc. Provides Earnings Guidance for the Full Year 2024	13/03
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic	11/03
KORU Medical Systems, Inc. Announces A Feasibility Study to Enter Ambulatory Infusion Settings with A Commercialized Biologic	11/03
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin	06/03
KORU Medical Systems, Inc. Signs Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for Novel Subcutaneous Immunoglobulin	06/03
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024	21/02
KORU Medical : Investor Day 2023 Presentation	05/12
KORU Medical Systems to Participate in Piper Sandler's 35th Annual Healthcare Conference	30/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues KORU Medical Systems, Inc.

Actions

KRMD

US7599101026

Autres langues

Filtres